Literature DB >> 2911129

Plaque size phenotype as a selectable marker to generate vaccinia virus recombinants.

J F Rodriguez1, M Esteban.   

Abstract

In this report, we provide a new method for selection of vaccinia virus recombinants expressing foreign genes. The method is based on the use of the gene encoding the viral 14,000-molecular-weight envelope protein that rescues the small-plaque-size phenotype of a vaccinia virus variant to large-plaque-size virus. Selection of recombinants is easily obtained after visual inspection of large viral plaques.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2911129      PMCID： PMC247783          DOI： 10.1128/JVI.63.2.997-1001.1989

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  14 in total

Review 1.  Vaccinia virus expression vectors.

Authors:  B Moss; C Flexner
Journal:  Annu Rev Immunol       Date:  1987       Impact factor: 28.527

2.  Virus attenuation and identification of structural proteins of vaccinia virus that are selectively modified during virus persistence.

Authors:  E Paez; S Dallo; M Esteban
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

3.  A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers.

Authors:  J F Rodriguez; E Paez; M Esteban
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

4.  Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype.

Authors:  R M Buller; G L Smith; K Cremer; A L Notkins; B Moss
Journal:  Nature       Date:  1985 Oct 31-Nov 6       Impact factor: 49.962

5.  Generation of a dominant 8-MDa deletion at the left terminus of vaccinia virus DNA.

Authors:  E Paez; S Dallo; M Esteban
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

6.  Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants.

Authors:  C A Franke; C M Rice; J H Strauss; D E Hruby
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

7.  Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus.

Authors:  J F Rodriguez; R Janeczko; M Esteban
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

8.  Vaccinia virus: a selectable eukaryotic cloning and expression vector.

Authors:  M Mackett; G L Smith; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

9.  Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.

Authors:  D Panicali; E Paoletti
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

10.  Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.

Authors:  S Chakrabarti; K Brechling; B Moss
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272
View more
  9 in total

1.  Recombinant vaccinia viruses. Design, generation, and isolation.

Authors:  C C Broder; P L Earl
Journal:  Mol Biotechnol       Date:  1999-12-15       Impact factor: 2.695

2.  Transient dominant selection of recombinant vaccinia viruses.

Authors:  F G Falkner; B Moss
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

Review 3.  Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.

Authors:  B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  Construction of fowlpox virus vectors with intergenic insertions: expression of the beta-galactosidase gene and the measles virus fusion gene.

Authors:  D Spehner; R Drillien; J P Lecocq
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

Review 5.  Vaccinia virus vectors: new strategies for producing recombinant vaccines.

Authors:  D E Hruby
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

6.  The purified 14-kilodalton envelope protein of vaccinia virus produced in Escherichia coli induces virus immunity in animals.

Authors:  C F Lai; S C Gong; M Esteban
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

7.  Methodology for the efficient generation of fluorescently tagged vaccinia virus proteins.

Authors:  N Bishara Marzook; Dean J Procter; Helena Lynn; Yui Yamamoto; Jacquelyn Horsington; Timothy P Newsome
Journal:  J Vis Exp       Date:  2014-01-17       Impact factor: 1.355

8.  A single point mutation of Ala-25 to Asp in the 14,000-Mr envelope protein of vaccinia virus induces a size change that leads to the small plaque size phenotype of the virus.

Authors:  S C Gong; C F Lai; S Dallo; M Esteban
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

Review 9.  CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development.

Authors:  Arinze Okoli; Malachy I Okeke; Morten Tryland; Ugo Moens
Journal:  Viruses       Date:  2018-01-22       Impact factor: 5.048
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.